Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder where antibodies target platelets, leading to their destruction in the spleen and resulting in reduced platelet counts. It often presents…
James Januzzi, MD, explores the use of cardiac biomarkers like natriuretic peptides and troponin in heart failure management. He discusses their evolution from diagnostic tools to predictors of…
Ellis Parker, MSN, RN, from Level Up RN, discusses the different levels of health prevention—primary, secondary, and tertiary—and the significant role of health determinants. She uses the community…
This video provides a comprehensive overview of pediatric asthma, focusing on how to approach a wheezing child. It differentiates between stridor and wheezing, explaining their causes and characteristics…
In this detailed webinar on systemic mastocytosis, Dr. Miti introduces Professor Prithviraj Bose, an expert in the field, who discusses the complexities of diagnosing and managing systemic mastocytosis…
In this medical training video, Elena Zanchini, MD, guides viewers through a comprehensive review of gastrointestinal and hepatological issues, focusing on diagnosing conditions such as infectious diarrhea and…
Alina Bridges, MD, a dermatologist and dermatopathologist at Mayo Clinic, explains psoriasis, a common chronic inflammatory disease affecting the skin, nails, and joints. In this video, she outlines…
Christopher Patriquin, MD, Hematologist at Toronto General Hospital, discusses the challenges of diagnosing paroxysmal nocturnal hemoglobinuria (PNH) due to its varied symptoms, such as thrombosis, anemia, and unusual…
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease where red blood cells rupture due to the immune system mistakenly attacking them. This happens because of a mutation…
Antonio Risitano, MD, PhD, highlights exciting developments in treatments for paroxysmal nocturnal hemoglobinuria (PNH), specifically the introduction of complement inhibitors that have transformed the prognosis of the disease.…
The meeting discusses the effectiveness and value of treatments for paroxysmal nocturnal hemoglobinuria (PNH). During the session, individual members introduce themselves, disclose conflicts of interest, and emphasize patient…
